Koninklijke Philips (NYSE:PHG) Shares Sold by Natixis Advisors L.P.

Natixis Advisors L.P. lowered its position in shares of Koninklijke Philips (NYSE:PHG - Free Report) by 6.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 838,201 shares of the technology company's stock after selling 53,060 shares during the period. Natixis Advisors L.P. owned 0.09% of Koninklijke Philips worth $19,555,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Allworth Financial LP grew its position in shares of Koninklijke Philips by 113.3% during the 3rd quarter. Allworth Financial LP now owns 3,242 shares of the technology company's stock valued at $65,000 after purchasing an additional 1,722 shares in the last quarter. Spire Wealth Management raised its holdings in Koninklijke Philips by 127.2% during the 3rd quarter. Spire Wealth Management now owns 3,446 shares of the technology company's stock valued at $69,000 after buying an additional 1,929 shares during the last quarter. Bruce G. Allen Investments LLC purchased a new stake in Koninklijke Philips during the 4th quarter valued at $140,000. GAMMA Investing LLC purchased a new stake in Koninklijke Philips during the 4th quarter valued at $146,000. Finally, PAX Financial Group LLC purchased a new stake in Koninklijke Philips during the 3rd quarter valued at $199,000. 13.67% of the stock is currently owned by hedge funds and other institutional investors.

Koninklijke Philips Trading Up 0.3 %

Shares of NYSE:PHG traded up $0.08 on Monday, hitting $26.90. The company had a trading volume of 1,798,326 shares, compared to its average volume of 1,192,286. The firm's 50-day simple moving average is $21.22 and its two-hundred day simple moving average is $21.27. Koninklijke Philips has a 1 year low of $17.75 and a 1 year high of $29.44. The company has a quick ratio of 0.78, a current ratio of 1.20 and a debt-to-equity ratio of 0.58. The firm has a market capitalization of $24.98 billion, a price-to-earnings ratio of -28.02, a P/E/G ratio of 1.39 and a beta of 0.75.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on PHG. UBS Group raised shares of Koninklijke Philips from a "sell" rating to a "neutral" rating in a research report on Tuesday, April 30th. BNP Paribas cut shares of Koninklijke Philips from an "outperform" rating to an "underperform" rating in a research report on Wednesday, February 7th. JPMorgan Chase & Co. raised shares of Koninklijke Philips from an "underweight" rating to a "neutral" rating in a research report on Tuesday, April 30th. Finally, StockNews.com raised shares of Koninklijke Philips from a "buy" rating to a "strong-buy" rating in a research report on Thursday, February 8th. One analyst has rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $19.00.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.